650E2-2B12, CMCC #10121 (IVI 10083) (ATCC® HB-10812)

Organism: Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma)  /  Cell Type: hybridoma: B lymphocyte; somatic cell hybri  / 

Permits and Restrictions

View Permits

Organism Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma)
Cell Type hybridoma: B lymphocyte; somatic cell hybri
Product Format frozen
Morphology lymphoblast
Culture Properties suspension
Biosafety Level 1
Age adult
Strain BALB/c
Tumorigenic Yes
Effects
Yes, BALB/c and (C57BL/6 X BALB/c)F1 mice
Complete Growth Medium Modified MA plus 10% fetal bovine serum.
Complete Growth Medium
Depositor's culture medium: Modified MA plus 10% fetal bovine serum.
Culture Conditions
Temperature: 37.0°C
Isotype IgG1
Name of Depositor Cetus Corp.
References

Ring DB, et al. Monoclonal anti-human breast cancer antibodies. US Patent 5,629,197 dated May 13 1997

Ring DB. Antigen-binding sites of antibody molecules specific for cancer antigens. US Patent 6,054,561 dated Apr 25 2000

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation
References

Ring DB, et al. Monoclonal anti-human breast cancer antibodies. US Patent 5,629,197 dated May 13 1997

Ring DB. Antigen-binding sites of antibody molecules specific for cancer antigens. US Patent 6,054,561 dated Apr 25 2000